• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>NCI

NCI

NCI Inc Class A NCIT

Last Price$10.21Day Change (%)0.79%
Open Price$10.20Day Change ($)0.08
Day Range10.03–10.2452-Week Range8.03–13.13

As of Fri 4/24/2015 5:00:00 PM | USD

  1. OncoCyte Announces Initial Data From Ongoing Clinical Study of Collagen Type X as a Marker and Potential Diagnostic for Breast Cancer and Other Types of Human Cancers

    OncoCyte Announces Initial Data From Ongoing Clinical Study of Collagen Type X as a Marker and Potential Diagnostic for Breast Cancer and Other Types of Human Cancers

  2. State of Oklahoma Receives CEO Cancer Gold Standard Accreditation

    State of Oklahoma Receives CEO Cancer Gold Standard Accreditation

  3. European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer

    European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer

  4. How the Hottest Biotech Sprouted in Iowa

    How the Hottest Biotech Sprouted in Iowa

  5. SL Green Realty Corp. Names Betsy Atkins as an Independent Director

    SL Green Realty Corp. Names Betsy Atkins as an Independent Director

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.